ICD-10 Code B46.1 | Rhinocerebral mucormycosis Symptoms, Diagnosis, Billing

Rhinocerebral mucormycosis is a severe fungal infection primarily affecting the nasal cavity and brain, caused by fungi from the Mucorales order. It is most commonly seen in immunocompromised patients, such as those with diabetes or undergoing chemotherapy. The ICD-10 Code B46.1 facilitates accurate diagnosis, documentation, and billing, ensuring proper treatment and public health reporting.

What is ICD-10 Code B46.1 for Rhinocerebral mucormycosis?

ICD-10 Code B46.1 specifically denotes rhinocerebral mucormycosis, a life-threatening fungal infection that affects the sinuses and can extend to the brain. This code is used when documenting cases of mucormycosis related to underlying conditions such as diabetes mellitus or immunosuppression, ensuring appropriate clinical management and billing.

ICD-10 Code B46.1 – Clinical Definition and Explanation of Rhinocerebral mucormycosis

Rhinocerebral mucormycosis is caused by the invasion of Mucorales fungi, often in individuals with compromised immune systems. The condition can progress rapidly, leading to severe complications, including necrosis of facial tissues and central nervous system involvement, necessitating urgent medical intervention.

Key Clinical Features:

• Rapid onset of symptoms including facial swelling and pain.
• Nasal discharge that may be black or bloody.
• Neurological symptoms such as altered mental status or cranial nerve deficits.
• History of immunosuppression or uncontrolled diabetes.

ICD-10 Code B46.1 for Rhinocerebral mucormycosis – SOAP Notes & Clinical Use

ICD-10 Code B46.1 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of rhinocerebral mucormycosis. It plays a critical role in both acute and chronic care settings, ensuring comprehensive patient management and accurate billing.

What Does ICD-10 Code B46.1 for Rhinocerebral mucormycosis Mean in SOAP Notes?

In SOAP notes, ICD-10 Code B46.1 connects subjective patient reports and objective clinical findings to a formal diagnosis of rhinocerebral mucormycosis. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code B46.1 – Rhinocerebral mucormycosis

Rhinocerebral mucormycosis requires urgent medical treatment, often necessitating hospitalization for effective management.

Antibiotic Therapy:

• First-line: Amphotericin B (liposomal formulation) for 4-6 weeks.
• Alternative: Posaconazole or Isavuconazole if Amphotericin B is contraindicated.
• Adjunctive therapy: Surgical debridement of necrotic tissue.

Supportive Care:

• Management of underlying conditions, such as diabetes.
• Fluid and electrolyte management.
• Pain control and nutritional support.

Infection Control:

• Implement standard precautions to prevent transmission.
• Isolate patients with severe immunosuppression.
• Educate healthcare staff on handling fungal infections.

How to Document Symptoms of Rhinocerebral mucormycosis (ICD-10 B46.1) in SOAP Notes

Subjective:

• Patient reports severe facial pain and swelling.
• Nasal discharge described as black and foul-smelling.
• History of poorly controlled diabetes.
• Recent sinus surgery noted.

Objective:

• Facial examination reveals swelling and necrotic tissue.
• CT scan shows sinus involvement with possible brain extension.
• Vital signs: Fever 101°F, tachycardia 110 bpm.
• Neurological exam shows cranial nerve deficits.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Rhinocerebral mucormycosis (ICD-10 Code B46.1)

Assessment:

• Diagnosis: Rhinocerebral mucormycosis, severe.
• ICD-10 Code: B46.1.
• Contributing factors: Uncontrolled diabetes, recent surgery.
• Severity: High risk of complications.

Plan:

• Initiate Amphotericin B therapy immediately.
• Consult infectious disease specialist.
• Schedule surgical debridement.
• Monitor blood glucose levels closely.

Treatment & Plan Section for ICD-10 Code B46.1 – Rhinocerebral mucormycosis

• Administer antifungal therapy as per guidelines.
• Educate patient on the importance of glycemic control.
• Implement regular monitoring of clinical status and laboratory parameters.
• Schedule follow-up appointments to assess treatment response.

Using ICD-10 Code B46.1 for Rhinocerebral mucormycosis in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings.
• Use B46.1 in acute care settings for appropriate reimbursement.
• Link treatment plans to documented diagnoses for compliance.
• Review coding guidelines to support billing accuracy.

Related ICD-10 Codes Often Used with Rhinocerebral mucormycosis

• B46.0 – Pulmonary mucormycosis
• B46.2 – Cutaneous mucormycosis
• B46.3 – Gastrointestinal mucormycosis
• B46.9 – Mucormycosis, unspecified

ICD-10 Code B46.1 in Medical Billing and Insurance for Rhinocerebral mucormycosis

ICD-10 Code B46.1 is crucial for billing in hospital, emergency room, or infectious disease care settings.

Billing Notes:

• Document all clinical findings thoroughly to support the diagnosis.
• Use B46.1 in conjunction with relevant procedure codes for accurate billing.
• Ensure compliance with payer-specific guidelines for documentation.
• Review patient history for any additional codes that may apply.

Common CPT Pairings: